These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1436 related items for PubMed ID: 17723086

  • 1. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ, Anderson S.
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [Abstract] [Full Text] [Related]

  • 2. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
    Williams B, Lacy PS, CAFE and the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators.
    J Am Coll Cardiol; 2009 Aug 18; 54(8):705-13. PubMed ID: 19679248
    [Abstract] [Full Text] [Related]

  • 3. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
    De Caterina AR, Leone AM.
    Am J Cardiol; 2010 May 15; 105(10):1433-8. PubMed ID: 20451690
    [Abstract] [Full Text] [Related]

  • 4. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M, CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee.
    Circulation; 2006 Mar 07; 113(9):1213-25. PubMed ID: 16476843
    [Abstract] [Full Text] [Related]

  • 5. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.
    Blood Press; 2007 Mar 07; 16(1):6-12. PubMed ID: 17453746
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 07; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J, Barbosa L, Silva JA, Bertoquini S.
    Blood Press Monit; 2010 Oct 07; 15(5):235-9. PubMed ID: 20577082
    [Abstract] [Full Text] [Related]

  • 8. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW.
    Am J Hypertens; 2005 Jan 07; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 1998 Jan 07; 16(1):S53-8. PubMed ID: 9534098
    [Abstract] [Full Text] [Related]

  • 10. Brachial arterial pressure to assess cardiovascular structural damage: an overview and lessons from clinical trials.
    London GM.
    J Nephrol; 2008 Jan 07; 21(1):23-31. PubMed ID: 18264933
    [Abstract] [Full Text] [Related]

  • 11. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 07; 23(2):443-57. PubMed ID: 17288698
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA, van Veldhuisen DJ, Gans RO, Gansevoort RT.
    Ned Tijdschr Geneeskd; 2003 Jan 18; 147(3):96-9. PubMed ID: 12577767
    [Abstract] [Full Text] [Related]

  • 13. Different influences on central and peripheral pulse pressure, aortic wave reflections and pulse wave velocity of three different types of antihypertensive drugs.
    Polónia J, Barbosa L, Silva JA, Maldonado J.
    Rev Port Cardiol; 2003 Dec 18; 22(12):1485-92. PubMed ID: 15008064
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM, Schmieder RE.
    Am J Hypertens; 2008 May 18; 21(5):500-8. PubMed ID: 18437140
    [Abstract] [Full Text] [Related]

  • 15. Beta-adrenergic antagonists in hypertension: a review of the evidence.
    Warmack TS, Estes MA, Heldenbrand S, Franks AM.
    Ann Pharmacother; 2009 Dec 18; 43(12):2031-43. PubMed ID: 19934392
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S, Messerli FH, Kostis JB, Pepine CJ.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):563-72. PubMed ID: 17692739
    [Abstract] [Full Text] [Related]

  • 17. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
    Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB.
    Am J Hypertens; 2006 Feb 14; 19(2):214-9. PubMed ID: 16448896
    [Abstract] [Full Text] [Related]

  • 18. Pulse pressure reduction and cardiovascular protection.
    Laurent S, Tropeano AI, Boutouyrie P.
    J Hypertens Suppl; 2006 May 14; 24(3):S13-8. PubMed ID: 16723861
    [Abstract] [Full Text] [Related]

  • 19. Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure.
    Adji A, Hirata K, Hoegler S, O'Rourke MF.
    Am J Hypertens; 2007 Aug 14; 20(8):917-22. PubMed ID: 17679043
    [Abstract] [Full Text] [Related]

  • 20. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 14; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.